Cardio Diagnostics to go public through deal with Mana Capital Acquisition (NASDAQ:MAAQ)
seekingalpha.com
finance
2022-05-31 18:44:02

gorodenkoff/iStock via Getty Images Cardio Diagnostics agreed to go public through a deal with Mana Capital Acquisition (NASDAQ:MAAQ). The combined company is expected to have an approximate post-transaction equity market capitalization of $175 million assuming no redemptions, according to a statement. Cardio Diagnostics is expected to have approximately $10 million in gross proceeds raised in 2022 from common stock equity investors prior to closing. The transaction is expected to close in the second half of the year.
